You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

stage I ovarian epithelial cancer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

HER2-positive Breast Cancer, Stage III Ovarian Epithelial Cancer, Stage III Ovarian Germ Cell Tumor Trial in Seattle

Active, not recruiting
  • HER2-positive Breast Cancer
  • +8 more
  • pNGVL3-hICD vaccine
  • +6 more
  • Seattle, Washington
    Fred Hutchinson Cancer Research Center/University of Washington
Nov 1, 2022

Advanced Fallopian Tube Carcinoma, Advanced Ovarian Carcinoma, Advanced Primary Peritoneal Carcinoma Trial in Portland (Wee1

Not yet recruiting
  • Advanced Fallopian Tube Carcinoma
  • +10 more
  • Wee1 Inhibitor ZN-c3
  • Portland, Oregon
    OHSU Knight Cancer Institute
Jan 25, 2023

Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube High Grade Serous Adenocarcinoma, Ovarian Endometrioid Adenocarcinoma

Recruiting
  • Fallopian Tube Endometrioid Adenocarcinoma
  • +17 more
  • Biopsy
  • +3 more
  • Augusta, Georgia
  • +4 more
Jan 25, 2023

Ovarian Cancer, Hyperthermic Intraperitoneal Chemo, Paclitaxel Trial in Guangzhou (Hyperthermic Intraperitoneal Paclitaxel

Recruiting
  • Ovarian Cancer
  • +2 more
  • Hyperthermic Intraperitoneal Paclitaxel Combined With Cisplatin
  • Guangzhou, Other (Non U.s.), China
    Sun Yat-sen Memorial Hospital
Nov 11, 2022

Developing a Test for the Detection of Ovarian Cancer

Recruiting
  • Ovarian Neoplasms
  • +14 more
  • Uterine lavage, or a wash of the womb
  • +2 more
  • Little Rock, Arkansas
  • +5 more
Apr 29, 2022

Advanced Malignant Solid Tumor, Refractory Malignant Solid Tumor, Refractory Ovarian Carcinoma Trial in Houston (TRPV6 Calcium

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +22 more
  • TRPV6 Calcium Channel Inhibitor SOR-C13
  • Houston, Texas
    M D Anderson Cancer Center
Oct 20, 2022

Ovarian Cancer Trial in Farmington (OncoImmunome)

Suspended
  • Ovarian Cancer
  • OncoImmunome
  • Farmington, Connecticut
    UConn Health
Jan 25, 2022

Among Reproductive Age Gynecological and Breast Cancer

Recruiting
  • Anatomic Stage I Breast Cancer AJCC v8
  • +29 more
  • Healthcare Activity
  • Survey Administration
  • Houston, Texas
    M D Anderson Cancer Center
Nov 2, 2022

Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube Mucinous Adenocarcinoma, Fallopian Tube Serous Adenocarcinoma Trial

Recruiting
  • Fallopian Tube Endometrioid Adenocarcinoma
  • +32 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Sep 16, 2022

Stage II Fallopian Tube Cancer AJCC v8, Stage II Ovarian Cancer AJCC v8, Stage II Primary Peritoneal Cancer AJCC v8 Trial in

Not yet recruiting
  • Stage II Fallopian Tube Cancer AJCC v8
  • +33 more
  • Alpha-type-1 Polarized Dendritic Cells
  • Autologous Natural Killer Cell-like CTLs
  • Buffalo, New York
    Roswell Park Cancer Institute
Apr 1, 2022

Fallopian Tube Carcinoma, Primary Peritoneal Carcinoma, Stage I Ovarian Cancer Trial in Buffalo (procedure, drug, other)

Completed
  • Fallopian Tube Carcinoma
  • +14 more
  • Diagnostic Microscopy
  • +2 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Oct 5, 2021

Malignant Female Reproductive System Tumor, Recurrent Cervical Carcinoma, Recurrent Endometrial Carcinoma Trial in Houston

Recruiting
  • Malignant Female Reproductive System Neoplasm
  • +24 more
  • Quality-of-Life Assessment
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Jun 6, 2022

Stage III Fallopian Tube Cancer AJCC v7, Stage III Ovarian Cancer AJCC v6 and v7, Stage III Primary Peritoneal Cancer AJCC v7

Active, not recruiting
  • Stage III Fallopian Tube Cancer AJCC v7
  • +14 more
  • Minneapolis, Minnesota
  • +1 more
Jan 27, 2023

Collecting Blood Samples From and Without Cancer to Evaluate

Not yet recruiting
  • Acute Lymphoblastic Leukemia
  • +61 more
  • Questionnaire Administration
  • Biospecimen Collection
  • (no location specified)
Apr 12, 2022

Remote Telemonitoring of Patient-Generated Physiologic Health

Recruiting
  • Clinical Stage 0 Esophageal Adenocarcinoma AJCC v8
  • +171 more
  • Patient Monitoring
  • Questionnaire Administration
  • Duarte, California
    City of Hope Medical Center
Aug 15, 2022

Metastatic Ovarian Carcinoma, Peritoneal Carcinomatosis, Stage III Ovarian Cancer Trial in Pierre-Bénite (Combined PIPAC / IV

Recruiting
  • Metastatic Ovarian Carcinoma
  • +6 more
  • Combined PIPAC / IV chemotherapy treatment
  • Pierre-Bénite, France
    Centre Hospitalier Lyon Sud
Aug 4, 2021

Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Tumor, Fallopian Tube Mucinous Tumor Trial in Rochester

Active, not recruiting
  • Fallopian Tube Clear Cell Adenocarcinoma
  • +22 more
  • Laboratory Biomarker Analysis
  • Multi-epitope Folate Receptor Alpha-loaded Dendritic Cell Vaccine
  • Rochester, Minnesota
    Mayo Clinic
Oct 7, 2022

Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube High Grade Serous

Active, not recruiting
  • Fallopian Tube Clear Cell Adenocarcinoma
  • +25 more
  • Goodyear, Arizona
  • +111 more
Jun 1, 2022

Advanced Breast Carcinoma, Advanced Endometrial Carcinoma, Advanced Fallopian Tube Carcinoma Trial in Houston (biological, drug,

Recruiting
  • Advanced Breast Carcinoma
  • +73 more
  • Atezolizumab
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
May 5, 2022

Stage III Ovarian Cancer, Stage IV Ovarian Cancer, Epithelial Ovarian Cancer Trial in Baltimore (procedure, drug, other)

Recruiting
  • Stage III Ovarian Cancer
  • +6 more
  • Cytoreductive Surgery (CRS)
  • +6 more
  • Baltimore, Maryland
    Mercy Medical Center
Aug 30, 2022

Stage III Ovarian Epithelial Cancer, Stage III Ovarian Germ Cell Tumor, Stage IV Ovarian Epithelial Cancer Trial in Seattle

Completed
  • Stage III Ovarian Epithelial Cancer
  • +3 more
  • pUMVC3-hIGFBP-2 multi-epitope plasmid DNA vaccine
  • laboratory biomarker analysis
  • Seattle, Washington
    Fred Hutchinson Cancer Research Center/University of Washington
Feb 22, 2021

Ovarian Cancer Trial in Goyang (Cisplatin)

Not yet recruiting
  • Ovarian Cancer
  • Goyang, Gyeonggi, Korea, Republic of
    National Cancer Center
Apr 24, 2023

Ovarian Cancer, Fallopian Tube Carcinoma, Peritoneal Carcinoma Trial in Italy (carboplatin and paclitaxel followed by surgery)

Active, not recruiting
  • Ovarian Cancer
  • +2 more
  • carboplatin and paclitaxel followed by surgery
  • Bologna, Italy
  • +4 more
Dec 28, 2022

Epithelial Ovarian Carcinoma Stage III, Epithelial Ovarian Carcinoma Stage IV, Fallopian Tube Carcinoma Stage III Trial in China

Recruiting
  • Epithelial Ovarian Carcinoma Stage III
  • +5 more
  • nab-paclitaxel combined with carboplatin
  • Guangzhou, Guangdong, China
  • +10 more
Feb 19, 2023

Fallopian Tube Carcinoma, Fallopian Tube Carcinosarcoma, Fallopian Tube Clear Cell Adenocarcinoma Trial in United States

Completed
  • Fallopian Tube Carcinoma
  • +37 more
  • Bevacizumab
  • +5 more
  • Birmingham, Alabama
  • +22 more
Oct 19, 2021